Anti-Human IgG1 antibody [R29-3R-6] (STJA0035526)

SKU:
STJA0035526
$184.23 - $388.47
Processing The item has been added

Host: Rabbit
Applications: WB
Reactivity: Human
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description : Rabbit monoclonal anti-Human IgG1 for use in WB in Human samples. Datasheet included with dilution recommendations, and related reagents.
Clonality : Monoclonal
Clone ID : R29-3R-6
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS, pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Purification: Affinity Chromatography
Dilution Range: WB 1:500-1:1000
Storage Instruction: Store at 4°C short term. Aliquot and store at-20°C long term. Avoid freeze/thaw cycles.
Gene Symbol: IGHG1Uniprot ID=IGHG1_HUMAN"
Immunogen: A synthesized peptide derived from human IgG1
Post Translational Modifications Glycosylation on Asn-180 is required for interaction with Fc receptors and ability to activate the complement pathway. (Microbial infection) Deglycosylation on Asn-180 by S.pyogenes EndoS or Endos2 endoglucosidases prevents interaction between immunoglobulin-gamma (IgG) and Fc receptors, impairing ability to activate the complement pathway.
Function Constant region of immunoglobulin heavy chains. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens. The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D)-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen. Mediates IgG effector functions on monocytes triggering ADCC of virus-infected cells.
Protein Name Immunoglobulin Heavy Constant Gamma 1
Ig Gamma-1 Chain C Region
Ig Gamma-1 Chain C Region Eu
Ig Gamma-1 Chain C Region Kol
Ig Gamma-1 Chain C Region Nie
Cellular Localisation Isoform 1: Secreted
Isoform 2: Cell Membrane
Single-Pass Membrane Protein
Alternative Antibody Names Anti-Immunoglobulin Heavy Constant Gamma 1 antibody
Anti-Ig Gamma-1 Chain C Region antibody
Anti-Ig Gamma-1 Chain C Region Eu antibody
Anti-Ig Gamma-1 Chain C Region Kol antibody
Anti-Ig Gamma-1 Chain C Region Nie antibody
Anti-IGHG1 antibody

Information sourced from Uniprot.org